9 completed, 3 unknown, 1 recruiting, 1 withdrawn. 14 Phase 3, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 14 | Completed 9, Unknown 3, Recruiting 1, Withdrawn 1 |
| Phase 2 | 4 | Completed 3, Withdrawn 1 |
Follow Diabetic Neuropathy: new trials by email Literature Review of Diabetic Neuropathy trials Research Report on Diabetic Neuropathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Extended-release Pregabalin for the Treatment of Neuropathic Pain in Patients With Diabetic Peripheral Neuropathy and Postherpetic Neuralgia Experimental: Pregabalin XR, Comparator: Dorene Tabs, Comparator placebo - Diabetic Neuropathy, Neuropathic Pain | Phase 3 | Recruiting | Brainfarma Industria Química e Farmacêutica S/A | 348 | 2026-06-18 | 2026-07-20 |
| Efficacy and Safety of KW21052 Compared to Lyrica in the Diabetic Patients With Neuropathic Pain KW21052, Lyrica, Lyrica (low dose) - Diabetic Neuropathy | Phase 3 | Unknown | KunWha Pharmaceutical Co., Ltd. | 394 | 2013-08-01 | 2013-05-29 |
| Neuroprotection by Tocotrienols in Type 1 and Type 2 Diabetes Mellitus Tocotrienol, Placebo - Diabetic Neuropathy, Cognitive Impairment | Phase 3 | Completed | Universiti Sains Malaysia | 300 | 2011-06-01 | 2017-05-04 |
| The Evaluation of Safety and Efficacy of JWHGWT on Diabetic Neuropathy placebo, JWHGWT - Diabetic Neuropathy | Phase 3 | Unknown | Taichung Veterans General Hospital | 120 | 2008-07-01 | 2009-06-18 |
| Diabetic Neuropathy Topical Treatment ketamine, vehicle gel, ketamine + clonidine - Diabetic Neuropathy, Pain | Phase 3 | Unknown | Irmandade da Santa Casa de Misericordia de Sao Paulo | 200 | 2008-04-01 | 2008-04-18 |
| An Evaluation of the Efficacy and Safety of E2007 in Patients With Painful Diabetic Neuropathy Placebo, E2007 (2 mg), E2007 (4 mg) - Diabetic Neuropathy | Phase 2 / Phase 3 | Completed | Eisai Inc. | 352 | 2007-06-01 | 2014-07-11 |
| A Safety and Efficacy Study for Tapentadol (CG5503) Extended Release for Patients With Painful Diabetic Peripheral Neuropathy CG5503, placebo - Diabetic Neuropathy | Phase 3 | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 395 | 2007-04-01 | 2013-07-19 |
| Safety and Efficacy of Dextromethorphan and Quinidine in the Treatment of the Pain of Diabetic Neuropathy Neurodex - Pain, Diabetic Neuropathy | Phase 3 | Completed | Avanir Pharmaceuticals | 450 | 2005-07-01 | 2016-07-14 |
| A Study of Sativex® for Pain Relief Due to Diabetic Neuropathy Sativex, Placebo - Pain, Diabetic Neuropathy | Phase 3 | Completed | Jazz Pharmaceuticals | 297 | 2005-07-01 | 2023-05-03 |
| Effects of Pulsatile Intravenous Insulin Delivery on Diabetic Neuropathy in pATIENTS (Pts) With Type 1 and Type 2 Diabetes Placebo, Pulsatile IV insulin delivery (humalog, humulin, novolog) - Diabetic Neuropathy | Phase 2 / Phase 3 | Withdrawn | Florida Atlantic University | 2005-02-01 | 2016-08-10 | |
| Safety and Efficacy of AS-3201 in the Treatment of Diabetic Sensorimotor Polyneuropathy ranirestat, (AS-3201) - Diabetic Neuropathy | Phase 3 | Completed | Sumitomo Pharma Co., Ltd. | 500 | 2004-10-01 | 2008-01-14 |
| A Follow-On Trial to Assess the Long Term Safety and Efficacy of SPM 927 in Painful Distal Diabetic Neuropathy lacosamide - Diabetic Neuropathy | Phase 2 / Phase 3 | Completed | UCB Pharma | 451 | 2004-09-01 | 2018-07-17 |
| A Trial to Assess the Efficacy and Safety of SPM 927 in Subjects With Painful Distal Diabetic Neuropathy SPM 927 - Diabetic Neuropathy | Phase 2 / Phase 3 | Completed | UCB Pharma | 496 | 2004-04-01 | 2014-09-22 |
| A Trial to Assess the Efficacy and Safety of SPM 927 (Lacosamide) in Subjects With Painful Distal Diabetic Neuropathy SPM 927 - Diabetic Neuropathy | Phase 3 | Completed | UCB Pharma | 357 | 2003-12-01 | 2014-09-22 |
Diabetic Neuropathies (14) · Neuralgia (3) · Pain (3) · Peripheral Nervous System Diseases (2) · Cognitive Dysfunction (1) · Diabetes Complications (1) · Hypoglycemia (1) · Neuralgia, Postherpetic (1) · Polyneuropathies (1)
Diabetes Mellitus (14) · Endocrine System Diseases (14) · Nervous System Diseases (14) · Neuromuscular Diseases (14) · Diabetes Complications (13) · Peripheral Nervous System Diseases (12) · Neurologic Manifestations (5) · Pathological Conditions, Signs and Symptoms (5) · Signs and Symptoms (5) · Pain (2) · Cognition Disorders (1) · Glucose Metabolism Disorders (1) · Mental Disorders (1) · Metabolic Diseases (1) · Neurocognitive Disorders (1)
2-(acetylamino)-3-methoxy-N-(phenylmethyl)-, (2R)- (3) · Clonidine (1) · Insulin Aspart (1) · Insulin Lispro (1) · Insulin, Regular, Human (1) · Ketamine (1) · Lacosamide (1) · Pregabalin (1) · Tapentadol (1) · Tocotrienols (1) · nabiximols (1) · perampanel (1) · ranirestat (1)
UCB Pharma (3) · Avanir Pharmaceuticals (1) · Brainfarma Industria Química e Farmacêutica S/A (1) · Eisai Inc. (1) · Florida Atlantic University (1) · Irmandade da Santa Casa de Misericordia de Sao Paulo (1) · Jazz Pharmaceuticals (1) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (1) · KunWha Pharmaceutical Co., Ltd. (1) · Sumitomo Pharma Co., Ltd. (1) · Taichung Veterans General Hospital (1) · Universiti Sains Malaysia (1)
United States (5) · Brazil (2) · Canada (1) · Germany (1) · Malaysia (1) · South Korea (1) · Taiwan (1) · United Kingdom (1)
Antonio Laurenza, M.D. (1) · Betty Tuller, PhD (1) · Chia-I Tsai, master (1) · Judymara L Gozzani, Investigator (1) · Kah Hay Yuen, PhD (1) · Kwang-Kuk Kim, M.D., Ph.D. (1) · Mariana Ferreira, Sports Nutrition (1) · Solomon Tesfaye, JCHMT FRCP (1)
PMID 18619874, PMID 19366965, PMID 19454870, PMID 20067958, PMID 21162697, PMID 22314263, PMID 23340531, PMID 29379943, PMID 35587172